RNXT
RenovoRx Inc
1.60$
-6.6%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -21,220.9% | -977.1% | |
| – | – | – | – | – | 0.0% | 0.2% | |
| – | – | – | – | – | 2,730.2% | 112.8% | |
| – | – | – | – | – | 651.2% | -22.0% | |
| – | – | – | – | – | 27.9% | 0.2% | |
| – | – | – | – | – | -27.9% | -0.2% | |
| – | – | – | – | – | 35,158.1% | 965.7% | |
| – | – | – | – | – | 13,909.3% | -11.6% | |
| – | – | – | – | – | -21,248.8% | -977.3% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.